Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 29, 2014
A novel transthyretin variant p.H110D (H90D) as a cause of familial amyloid polyneuropathy in a large Irish kindredVictor H Jimenez-Zepeda, Nizar J Bahlis, Janet Gilbertson, et al.
British Journal of Haematology|November 26, 2013
Autologous stem cell transplant is an effective therapy for carefully selected patients with AL amyloidosis: experience of a single institutionVictor H Jimenez-Zepeda, Norman Franke, Donna E Reece, et al.
Clinical Transplantation|November 9, 2017
Risk factors for post-transplant lymphoproliferative disorder after Thymoglobulin-conditioned hematopoietic cell transplantationAmit Kalra, Cameron Roessner, Jennifer Jupp, et al.
Cytotherapy|March 28, 2018
Epstein-barr virus DNAemia monitoring for the management of post-transplant lymphoproliferative disorderAmit Kalra, Cameron Roessner, Jennifer Jupp, et al.
Blood Advances|January 4, 2018
Zoster prophylaxis after allogeneic hematopoietic cell transplantation using acyclovir/valacyclovir followed by vaccinationKareem Jamani, Judy MacDonald, Martin Lavoie, et al.
Annals of Hematology|August 26, 2022
Amyloidosis and COVID-19: experience from an amyloid program in CanadaEllen Lewis, Nowell Fine, Robert J H Miller, et al.
British Journal of Haematology|June 19, 2013
Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agentsChristine I Chen, Esther Masih-Khan, Haiyan Jiang, et al.
British Journal of Haematology|February 9, 2021
Real-world outcomes with bortezomib-containing regimens and lenalidomide plus dexamethasone for the treatment of transplant-ineligible multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group databaseVictor H Jimenez-Zepeda, Christopher Venner, Arleigh McCurdy, et al.
Ejhaem|December 5, 2022
Understanding real-world treatment patterns and clinical outcomes in AL amyloidosis patients diagnosed in Canada: A population-based cohort studyVictor H Jimenez-Zepeda, Donna Reece, Rodrigo Rigo, et al.
Blood Advances|May 3, 2019
Antirelapse effect of pretransplant exposure to rabbit antithymocyte globulinRosy Dabas, Kareem Jamani, Shahbal B Kangarloo, et al.
Pageof 8